17 days ago, listed pharma company bagged new order worth USD 2,79,000 from a pharma company in West Africa

Asston Pharmaceuticals Limited has secured an international purchase order from a pharma company in West Africa for the supply of various pharmaceutical products, valued at USD 279,000. This order is to be executed within a timeframe of 60 days, or approximately two months, further solidifying Asston Pharmaceuticals' presence and export capabilities in the African market.

Earlier, Asston Pharmaceuticals Limited announced receiving a new domestic purchase order from a leading pharma player. This order, valued at Rs 6,52,00,000 (including GST), is for supplying various pharmaceutical products and is to be executed within 60 days. The payment terms are set at a 20% advance with the balance due upon delivery, reinforcing Asston Pharmaceuticals' dedication to providing high-quality manufacturing solutions and solidifying its standing in the pharmaceutical industry.

About the Company

Established in 2019, Asston Pharmaceuticals Limited manufactures and exports pharmaceutical formulations and nutraceuticals under its "Asston" brand. Operating with a diversified model, the company engages in direct sales, contract manufacturing for third parties, and significant exports, primarily to African markets. Its USFDA-approved facility in Ambernath, Maharashtra, supports a broad product portfolio and boasts over 150 registered trademarks.

For the period ended March 31, 2025, Asston Pharmaceuticals reported a revenue from operations of Rs 25.04 crore and a net profit of Rs 4.33 crore. The company currently holds a market capitalisation of Rs 95 crore. Its shares exhibit a Price-to-Earnings (PE) ratio of 25x, aligning with the industry average, and demonstrate strong profitability metrics with a Return on Equity (ROE) of 68 per cent and a Return on Capital Employed (ROCE) of 50 per cent.

Disclaimer: The article is for informational purposes only and not investment advice.